(Source: ASCO - American Society of Clinical Oncology) ASCO Perspective 'Glioblastoma is frequently diagnosed in older individuals, and these are important data showing that our best therapies can work and be tolerable for elderly patients,' said Brian Alexander, MD, MPH, ASCO Expert in brain cancers. 'It's good to have an option to offer patients that we know can have a positive impact, though still physicians and their patients need to weigh the benefits of this approach carefully.' CHICAGO - A Canadian-led randomized phase III trial found that adding temozolomide (Temodar) chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide,...
↧